市場調査レポート
商品コード
1060585

性感染症検査の世界市場:疾患タイプ別・検査場所別・地域別展望、業界分析、および予測 (2021年~2027年)

Global Sexually Transmitted Diseases Testing Market By Disease Type, By the Location of Testing, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 193 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
性感染症検査の世界市場:疾患タイプ別・検査場所別・地域別展望、業界分析、および予測 (2021年~2027年)
出版日: 2022年01月31日
発行: KBV Research
ページ情報: 英文 193 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の性感染症検査の市場規模は、予測期間中に4.5%のCAGRで成長し、2027年には1,199億5,000万米ドルに達すると予測されます。

COVID-19のパンデミックは公衆衛生上の災害であり、性感染症検査市場にマイナスの影響を与えていると考えられます。また、輸出入の禁止やサプライチェーンの混乱などが、性感染症検査キットの需要を妨げているため、今後数年間の市場の成長を抑制すると予想されます。

当レポートでは、世界の性感染症検査市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 競合分析-世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的開発
  • トップウィニング戦略

第4章 世界の性感染症検査市場:疾患タイプ別

  • 世界のクラミジア市場:地域別
  • 世界の単純ヘルペスウイルス市場:地域別
  • 世界の淋病市場:地域別
  • 世界の梅毒市場:地域別
  • 世界のヒトパピローマウイルス(HPV)市場:地域別
  • 世界のその他の疾患市場:地域別

第5章 世界の性感染症検査市場:検査場所別

  • 世界のラボ試験市場:地域別
  • 世界のポイントオブケア(POC)検査市場:地域別

第6章 世界の性感染症検査市場:地域別

  • 北米の性感染症検査市場
  • 欧州の性感染症検査市場
  • アジア太平洋の性感染症検査市場
  • ラテンアメリカ・中東・アフリカの性感染症検査市場

第7章 企業プロファイル

  • BioMerieux S.A.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • DiaSorin Molecular LLC
  • Danaher Corporation
  • Bio-Rad laboratories, Inc.
  • OraSure Technologies, Inc.
図表

LIST OF TABLES

  • TABLE 1 Global Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 2 Global Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Sexually Transmitted Diseases (STD) Testing Market
  • TABLE 4 Product Launches And Product Expansions- Sexually Transmitted Diseases (STD) Testing Market
  • TABLE 5 Acquisition and Mergers- Sexually Transmitted Diseases (STD) Testing Market
  • TABLE 6 approvals and trials- Sexually Transmitted Diseases (STD) Testing Market
  • TABLE 7 Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 8 Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 9 Global Chlamydia Market by Region, 2017 - 2020, USD Million
  • TABLE 10 Global Chlamydia Market by Region, 2021 - 2027, USD Million
  • TABLE 11 Global Herpes simplex virus Market by Region, 2017 - 2020, USD Million
  • TABLE 12 Global Herpes simplex virus Market by Region, 2021 - 2027, USD Million
  • TABLE 13 Global Gonorrhea Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Gonorrhea Market by Region, 2021 - 2027, USD Million
  • TABLE 15 Global Syphilis Market by Region, 2017 - 2020, USD Million
  • TABLE 16 Global Syphilis Market by Region, 2021 - 2027, USD Million
  • TABLE 17 Global Human papillomavirus (HPV) Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Human papillomavirus (HPV) Market by Region, 2021 - 2027, USD Million
  • TABLE 19 Global Other Disease Market by Region, 2017 - 2020, USD Million
  • TABLE 20 Global Other Disease Market by Region, 2021 - 2027, USD Million
  • TABLE 21 Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 22 Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 23 Global Laboratory Testing Market by Region, 2017 - 2020, USD Million
  • TABLE 24 Global Laboratory Testing Market by Region, 2021 - 2027, USD Million
  • TABLE 25 Global Point of care (POC) Testing Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Point of care (POC) Testing Market by Region, 2021 - 2027, USD Million
  • TABLE 27 Global Sexually Transmitted Diseases (STD) Testing Market by Region, 2017 - 2020, USD Million
  • TABLE 28 Global Sexually Transmitted Diseases (STD) Testing Market by Region, 2021 - 2027, USD Million
  • TABLE 29 North America Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 30 North America Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 31 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 32 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 33 North America Chlamydia Market by Country, 2017 - 2020, USD Million
  • TABLE 34 North America Chlamydia Market by Country, 2021 - 2027, USD Million
  • TABLE 35 North America Herpes simplex virus Market by Country, 2017 - 2020, USD Million
  • TABLE 36 North America Herpes simplex virus Market by Country, 2021 - 2027, USD Million
  • TABLE 37 North America Gonorrhea Market by Country, 2017 - 2020, USD Million
  • TABLE 38 North America Gonorrhea Market by Country, 2021 - 2027, USD Million
  • TABLE 39 North America Syphilis Market by Country, 2017 - 2020, USD Million
  • TABLE 40 North America Syphilis Market by Country, 2021 - 2027, USD Million
  • TABLE 41 North America Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
  • TABLE 42 North America Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
  • TABLE 43 North America Other Disease Market by Country, 2017 - 2020, USD Million
  • TABLE 44 North America Other Disease Market by Country, 2021 - 2027, USD Million
  • TABLE 45 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 46 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 47 North America Laboratory Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Laboratory Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 49 North America Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 50 North America Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 51 North America Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 52 North America Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 53 US Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 54 US Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 55 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 56 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 57 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 58 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 59 Canada Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 60 Canada Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 61 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 62 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 63 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 64 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 65 Mexico Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 66 Mexico Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 67 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 68 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 69 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 70 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 71 Rest of North America Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 72 Rest of North America Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 73 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 74 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 75 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 76 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 77 Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 78 Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 79 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 80 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 81 Europe Chlamydia Market by Country, 2017 - 2020, USD Million
  • TABLE 82 Europe Chlamydia Market by Country, 2021 - 2027, USD Million
  • TABLE 83 Europe Herpes simplex virus Market by Country, 2017 - 2020, USD Million
  • TABLE 84 Europe Herpes simplex virus Market by Country, 2021 - 2027, USD Million
  • TABLE 85 Europe Gonorrhea Market by Country, 2017 - 2020, USD Million
  • TABLE 86 Europe Gonorrhea Market by Country, 2021 - 2027, USD Million
  • TABLE 87 Europe Syphilis Market by Country, 2017 - 2020, USD Million
  • TABLE 88 Europe Syphilis Market by Country, 2021 - 2027, USD Million
  • TABLE 89 Europe Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
  • TABLE 90 Europe Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
  • TABLE 91 Europe Other Disease Market by Country, 2017 - 2020, USD Million
  • TABLE 92 Europe Other Disease Market by Country, 2021 - 2027, USD Million
  • TABLE 93 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 94 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 95 Europe Laboratory Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 96 Europe Laboratory Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 97 Europe Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 98 Europe Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 99 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 100 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 101 Germany Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 102 Germany Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 103 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 104 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 105 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 106 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 107 UK Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 108 UK Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 109 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 110 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 111 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 112 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 113 France Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 114 France Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 115 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 116 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 117 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 118 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 119 Russia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 120 Russia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 121 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 122 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 123 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 124 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 125 Spain Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 126 Spain Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 127 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 128 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 129 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 130 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 131 Italy Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 132 Italy Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 133 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 134 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 135 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 136 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 137 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 138 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 139 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 140 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 141 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 142 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 143 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 144 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 145 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 146 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 147 Asia Pacific Chlamydia Market by Country, 2017 - 2020, USD Million
  • TABLE 148 Asia Pacific Chlamydia Market by Country, 2021 - 2027, USD Million
  • TABLE 149 Asia Pacific Herpes simplex virus Market by Country, 2017 - 2020, USD Million
  • TABLE 150 Asia Pacific Herpes simplex virus Market by Country, 2021 - 2027, USD Million
  • TABLE 151 Asia Pacific Gonorrhea Market by Country, 2017 - 2020, USD Million
  • TABLE 152 Asia Pacific Gonorrhea Market by Country, 2021 - 2027, USD Million
  • TABLE 153 Asia Pacific Syphilis Market by Country, 2017 - 2020, USD Million
  • TABLE 154 Asia Pacific Syphilis Market by Country, 2021 - 2027, USD Million
  • TABLE 155 Asia Pacific Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
  • TABLE 156 Asia Pacific Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
  • TABLE 157 Asia Pacific Other Disease Market by Country, 2017 - 2020, USD Million
  • TABLE 158 Asia Pacific Other Disease Market by Country, 2021 - 2027, USD Million
  • TABLE 159 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 160 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 161 Asia Pacific Laboratory Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 162 Asia Pacific Laboratory Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 163 Asia Pacific Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 164 Asia Pacific Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 165 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 166 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 167 China Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 168 China Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 169 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 170 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 171 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 172 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 173 Japan Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 174 Japan Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 175 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 176 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 177 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 178 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 179 India Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 180 India Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 181 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 182 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 183 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 184 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 185 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 186 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 187 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 188 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 189 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 190 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 191 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 192 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 193 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 194 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 195 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 196 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 197 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 198 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 199 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 200 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 201 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 202 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 203 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 204 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 205 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 206 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 207 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 208 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 209 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 210 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 211 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 212 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 213 LAMEA Chlamydia Market by Country, 2017 - 2020, USD Million
  • TABLE 214 LAMEA Chlamydia Market by Country, 2021 - 2027, USD Million
  • TABLE 215 LAMEA Herpes simplex virus Market by Country, 2017 - 2020, USD Million
  • TABLE 216 LAMEA Herpes simplex virus Market by Country, 2021 - 2027, USD Million
  • TABLE 217 LAMEA Gonorrhea Market by Country, 2017 - 2020, USD Million
  • TABLE 218 LAMEA Gonorrhea Market by Country, 2021 - 2027, USD Million
  • TABLE 219 LAMEA Syphilis Market by Country, 2017 - 2020, USD Million
  • TABLE 220 LAMEA Syphilis Market by Country, 2021 - 2027, USD Million
  • TABLE 221 LAMEA Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
  • TABLE 222 LAMEA Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
  • TABLE 223 LAMEA Other Disease Market by Country, 2017 - 2020, USD Million
  • TABLE 224 LAMEA Other Disease Market by Country, 2021 - 2027, USD Million
  • TABLE 225 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 226 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 227 LAMEA Laboratory Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 228 LAMEA Laboratory Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 229 LAMEA Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 230 LAMEA Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 231 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
  • TABLE 232 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
  • TABLE 233 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 234 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 235 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 236 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 237 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 238 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 239 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 240 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 241 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 242 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 243 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 244 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 245 UAE Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 246 UAE Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 247 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 248 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 249 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 250 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 251 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 252 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 253 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 254 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 255 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 256 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 257 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 258 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 259 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 260 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 261 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 262 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 263 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 264 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 265 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 266 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 267 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 268 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 269 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
  • TABLE 270 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
  • TABLE 271 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
  • TABLE 272 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
  • TABLE 273 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
  • TABLE 274 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
  • TABLE 275 Key information - BioMerieux S.A.
  • TABLE 276 Key Information - Abbott Laboratories
  • TABLE 277 Key information - Becton, Dickinson and Company
  • TABLE 278 Key information - Hologic, Inc.
  • TABLE 279 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 280 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 281 Key information - DiaSorin Molecular LLC
  • TABLE 282 Key Information - Danaher Corporation
  • TABLE 283 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 284 Key information - OraSure Technologies, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 1 KBV Cardinal Matrix
  • FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 3 Key Strategic Move: (Product Launches and Product Expansions : 2019, Oct - 2021, dec) Leading Players
  • FIG 4 Recent strategies and developments: Hologic, Inc.
  • FIG 5 Swot analysis: thermo fisher scientific, inc.
  • FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 7 Recent strategies and developments: OraSure Technologies, Inc.
目次

The Global Sexually Transmitted Diseases (STD) Testing Market size is expected to reach $119.95 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.

Infections transmitted from an infected person to an uninfected person through sexual intercourse are known as sexually transmitted diseases (STDs). Vaginal, oral, or anal sex are the most common forms of sexual contacts through which STDs get transmitted. Additionally, these diseases can spread through other forms of intimate physical contact also. This is due to the fact that some STDs, such as herpes and HPV, are spread through skin-to-skin contact since some of them are caused by Bacteria, viruses, or parasites. Gonorrhea, genital herpes, human papillomavirus infection, HIV/AIDS, chlamydia, and syphilis are only a few examples of STDs.

HIV/AIDS has consistently rated among the top ten leading causes of death for decades. In developed countries, testing and treatment have considerably reduced the disease's impact and prevalence. However, among younger groups, there has been a substantial increase in infection rates.

COVID-19 Impact Analysis

The COVID-19 pandemic is a public health disaster that has a negative impact on the STD testing market. Sexually transmitted infection cases were high prior to the pandemic, but following the pandemic, STD testing cases have reduced. Due to difficulties in health care and sexually transmitted infection testing services during the early months of the COVID-19 pandemic, testing reports of sexually transmitted infections were declined.

Due to a scarcity of intensive care resources, efforts were concentrated on ensuring the availability of critical care services. In addition, the imposition of restrictions like the ban on imports & exports and disruption in the supply chain have hampered the demand for STD testing kits and hence, hinder the growth of the STD testing market in the upcoming years.

Market Growth Factors:

Increasing awareness among population

There are many governments across developed and developing nations who are trying to aware people regarding the importance of early testing of STDs. For this, government and other healthcare authorities have strategized various campaigns for creating awareness among people regarding STDs. For example, CDC has initiated STD Awareness Week, which held in the second week of April. Also, many other renowned healthcare organizations are running campaigns for the same in their respective regions or even worldwide.

Rising government investments or funds

Several government authorities are increasing their investment in the development of fast and effective STD testing since it helps them to control the cases of STDs by providing correct medications at the correct time. The death rate of people having STDs is significantly high because patients do not get tested with correct measures at right time, which makes their condition more vulnerable and difficult to treat.

Market Restraining Factors:

Weak health services for screening and curing STDs

People seeking STI testing and treatment face numerous issues. Limited resources, poor service quality, and little or no sexual partner follow-up are among them. STI services are given independently in many countries and are not included in primary health care, family planning, or other regular health treatments. Because of a shortage of qualified employees, laboratory capacity, and adequate supply of relevant medicines, many services are unable to perform screening for asymptomatic infections.

Disease Type Outlook

Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Gonorrhea segment is estimated to garner a substantial share in the market during the forecast period. The bacteria Neisseria gonorrhoeae causes gonorrhoea, which is a sexually transmitted illness (STD).

Location of Testing Outlook

Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Point of care testing refers to the medical diagnostic testing done in the nearby care center. People who have not undergone professional laboratory training can also undertake POC testing.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific emerged as the leading region in the sexually transmitted diseases market with the largest revenue share and is projected to continue this trend during the forecast period. This is due to an increase in the number of cases of sexually transmitted illnesses in developing countries like China and Japan.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Sexually Transmitted Diseases (STD) Testing Market. Companies such as Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. are some of the key innovators in the Market

Strategies deployed in Sexually Transmitted Diseases (STD) Testing Market

Partnerships, Collaborations & Agreements:

Jun-2020: Roche formed a partnership with SpeeDx, a developer of innovative molecular diagnostic solutions. This partnership aimed to enable Roche Diagnostics to offer clinicians critical and advanced tools for the detection of antibiotic resistance in patients with sexually transmitted infections.

Apr-2017: Thermo Fisher Scientific entered into a partnership with SpeeDx, a provider of innovative multiplex and isothermal amplification solutions for clinical diagnostics. This partnership aimed to get FDA clearance of the Australian developer's ResistancePlus MG molecular diagnostic for the sexually transmitted infection, which is constantly developing into an antibiotic-resistant superbug.

Product Launches and Product Expansions:

Dec-2021: Becton, Dickinson, and Company (BD) expanded its BD COR System to involve the latest MX instrument for high-throughput infectious diseases testing. This accessibility of the MX instrument would expand the usage of the platform and automate testing for an expanding list of high-demand, important assays for women's health & STI testing utilizing multiplex PCR assay design, beginning with BD's CTGCTV2 test.

Dec-2021: Hologic unveiled Panther Trax that presents the new addition to the Panther Scalable Solutions (PSS) portfolio of products. This product would offer advancement in lab automation by physically connecting various Panther instruments together into one, powerful work cell, which would enable labs to boost testing volumes without raising the number of staff.

Sep-2020: Roche released the Elecsys HIV Duo immunoassay in the U.S., which has received FDA approval. By this separate measurement of the anti-HIV antibodies (caused by immune reaction) and HIV p24 antigen (the virus), this test can be used to identify an acute HIV infection prior to their existing methods.

Oct-2019: Novosanis, a subsidiary of OraSure Technologies released two variants of its urine-capturing device, Colli-Pee. The latest variants enable the collection of smaller and bigger amounts of first-void urine in comparison to the original 20 mL device, which would provide additional applications in the area of uro-oncology, infectious disease, and beyond.

Acquisitions and Mergers:

Mar-2021: Hologic took over Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products. This acquisition aimed to strengthen its molecular diagnostics business by expanding its international capabilities, enhancing its regional time-to-market, and enabling the company to provide a wider, more differentiated test menu.

Feb-2020: Bio-Rad Laboratories acquired Exact Diagnostics, developer of various diagnostic products. This acquisition aimed to access a complete catalog of molecular quality control products in the field of respiratory, transplant, virology, sexually transmitted infections, microbiology, and vector-borne diseases.

Jan-2019: OraSure Technologies completed the acquisition of Novosanis, a privately-held, Belgian company. The acquisition aimed to represent a clear fit in its stated 'core growth strategy for the Molecular business in order to expand its portfolio of collection products beyond oral samples by leveraging its expertise in stabilization and collection tools & technologies, which is utilized at home or in the clinic.

Approvals and Trials:

May-2019: Hologic got the FDA clearance for its new Aptima BV and Aptima CV/TV assays. This clearance would offer a precise and objective way for diagnosing vaginitis, which is a very common and complicated health issue affecting millions of women every year.

Mar-2019: Abbott received CE Mark for its Alinity m diagnostics system and assays. This latest technology would assist in keeping up with the rising demand for infectious disease testing. Alinity m provides initial assays that include virologic testing for human immunodeficiency virus type 1 (HIV-1), sexual health-related testing for Chlamydia trachomatis, Trichomonas vaginalis, Neisseria gonorrhoeae, and Mycoplasma genitalium or CT/NG/TV/MG panel; hepatitis B virus (HBV) and hepatitis C virus (HCV); and high-risk human papillomavirus (HPV) testing.

Jan-2019: Hologic received clearance from the U.S. Food and Drug Administration (FDA) for its Aptima Mycoplasma genitalium assay. This essay is the first and only FDA-cleared test to identify the under-recognized as well as highly common sexually transmitted infection (STI). The launch of the Aptima Mycoplasma genitalium assay would provide healthcare professionals the opportunity to offer optimal care for their patients and support Hologic's mission to develop advanced solutions that fulfill the emerging public health threats.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

  • Chlamydia
  • Herpes simplex
  • Gonorrhea
  • Syphilis
  • Human papillomavirus (HPV)
  • Other Disease

By Location of Testing

  • Laboratory Testing
  • Point of care (POC) Testing

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • BioMerieux S.A.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • DiaSorin Molecular LLC
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • OraSure Technologies, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
    • 1.4.2 Global Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
    • 1.4.3 Global Sexually Transmitted Diseases (STD) Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
    • 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct - 2021, Dec) Leading Players

Chapter 4. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type

  • 4.1 Global Chlamydia Market by Region
  • 4.2 Global Herpes simplex virus Market by Region
  • 4.3 Global Gonorrhea Market by Region
  • 4.4 Global Syphilis Market by Region
  • 4.5 Global Human papillomavirus (HPV) Market by Region
  • 4.6 Global Other Disease Market by Region

Chapter 5. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

  • 5.1 Global Laboratory Testing Market by Region
  • 5.2 Global Point of care (POC) Testing Market by Region

Chapter 6. Global Sexually Transmitted Diseases (STD) Testing Market by Region

  • 6.1 North America Sexually Transmitted Diseases (STD) Testing Market
    • 6.1.1 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
      • 6.1.1.1 North America Chlamydia Market by Country
      • 6.1.1.2 North America Herpes simplex virus Market by Country
      • 6.1.1.3 North America Gonorrhea Market by Country
      • 6.1.1.4 North America Syphilis Market by Country
      • 6.1.1.5 North America Human papillomavirus (HPV) Market by Country
      • 6.1.1.6 North America Other Disease Market by Country
    • 6.1.2 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.1.2.1 North America Laboratory Testing Market by Country
      • 6.1.2.2 North America Point of care (POC) Testing Market by Country
    • 6.1.3 North America Sexually Transmitted Diseases (STD) Testing Market by Country
      • 6.1.3.1 US Sexually Transmitted Diseases (STD) Testing Market
        • 6.1.3.1.1 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.1.3.1.2 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.1.3.2 Canada Sexually Transmitted Diseases (STD) Testing Market
        • 6.1.3.2.1 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.1.3.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.1.3.3 Mexico Sexually Transmitted Diseases (STD) Testing Market
        • 6.1.3.3.1 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.1.3.3.2 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.1.3.4 Rest of North America Sexually Transmitted Diseases (STD) Testing Market
        • 6.1.3.4.1 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.1.3.4.2 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
  • 6.2 Europe Sexually Transmitted Diseases (STD) Testing Market
    • 6.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
      • 6.2.1.1 Europe Chlamydia Market by Country
      • 6.2.1.2 Europe Herpes simplex virus Market by Country
      • 6.2.1.3 Europe Gonorrhea Market by Country
      • 6.2.1.4 Europe Syphilis Market by Country
      • 6.2.1.5 Europe Human papillomavirus (HPV) Market by Country
      • 6.2.1.6 Europe Other Disease Market by Country
    • 6.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.2.1 Europe Laboratory Testing Market by Country
      • 6.2.2.2 Europe Point of care (POC) Testing Market by Country
    • 6.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market by Country
      • 6.2.3.1 Germany Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.1.1 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.1.2 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.2 UK Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.2.1 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.2.2 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.3 France Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.3.1 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.3.2 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.4 Russia Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.4.1 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.4.2 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.5 Spain Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.5.1 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.5.2 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.6 Italy Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.6.1 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.6.2 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.2.3.7 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
        • 6.2.3.7.1 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.2.3.7.2 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
  • 6.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
    • 6.3.1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
      • 6.3.1.1 Asia Pacific Chlamydia Market by Country
      • 6.3.1.2 Asia Pacific Herpes simplex virus Market by Country
      • 6.3.1.3 Asia Pacific Gonorrhea Market by Country
      • 6.3.1.4 Asia Pacific Syphilis Market by Country
      • 6.3.1.5 Asia Pacific Human papillomavirus (HPV) Market by Country
      • 6.3.1.6 Asia Pacific Other Disease Market by Country
    • 6.3.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.2.1 Asia Pacific Laboratory Testing Market by Country
      • 6.3.2.2 Asia Pacific Point of care (POC) Testing Market by Country
    • 6.3.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country
      • 6.3.3.1 China Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.1.1 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.1.2 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.2 Japan Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.2.1 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.2.2 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.3 India Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.3.1 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.3.2 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.4 South Korea Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.4.1 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.4.2 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.5 Singapore Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.5.1 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.5.2 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.6 Malaysia Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.6.1 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.6.2 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.3.3.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
        • 6.3.3.7.1 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.3.3.7.2 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
  • 6.4 LAMEA Sexually Transmitted Diseases (STD) Testing Market
    • 6.4.1 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
      • 6.4.1.1 LAMEA Chlamydia Market by Country
      • 6.4.1.2 LAMEA Herpes simplex virus Market by Country
      • 6.4.1.3 LAMEA Gonorrhea Market by Country
      • 6.4.1.4 LAMEA Syphilis Market by Country
      • 6.4.1.5 LAMEA Human papillomavirus (HPV) Market by Country
      • 6.4.1.6 LAMEA Other Disease Market by Country
    • 6.4.2 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.2.1 LAMEA Laboratory Testing Market by Country
      • 6.4.2.2 LAMEA Point of care (POC) Testing Market by Country
    • 6.4.3 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country
      • 6.4.3.1 Brazil Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.1.1 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.1.2 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.2 Argentina Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.2.1 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.2.2 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.3 UAE Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.3.1 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.3.2 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.4.1 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.4.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.5 South Africa Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.5.1 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.6 Nigeria Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.6.1 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.6.2 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
      • 6.4.3.7 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market
        • 6.4.3.7.1 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
        • 6.4.3.7.2 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

Chapter 7. Company Profiles

  • 7.1 BioMerieux S.A.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Research & Development Expenses
  • 7.2 Abbott Laboratories
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trials:
  • 7.3 Becton, Dickinson and Company
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
  • 7.4 Hologic, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Approvals and Trials:
      • 7.4.5.2 Product Launches and Product Expansions:
      • 7.4.5.3 Acquisition and Mergers:
  • 7.5 Thermo Fisher Scientific, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
    • 7.5.6 SWOT Analysis
  • 7.6 F. Hoffmann-La Roche Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
      • 7.6.5.2 Product Launches and Product Expansions:
  • 7.7 DiaSorin Molecular LLC
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expenses
  • 7.8 Danaher Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Bio-Rad laboratories, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Acquisition and Mergers:
  • 7.10. OraSure Technologies, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Regional & Segmental Analysis
    • 7.10.4 Research & Development Expenses
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Product Launches and Product Expansions:
      • 7.10.5.2 Acquisition and Mergers: